Showing results (191-200 of 2,502) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|February 14, 2019
Allergic contact dermatitis caused by isobornyl acrylate when using the FreeStyle® LibreYusuke Mine, Tatsuhiko Urakami, Daisuke MatsuuraJournal of Diabetes Investigation|December 8, 2020
Forty-eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areasXieda Zhou, Liting Wu, Yan Chen, et al.Journal of Diabetes Investigation|November 27, 2020
Sodium-glucose cotransporter inhibitors as add-on therapy in addition to insulin for type 1 diabetes mellitus: A meta-analysis of randomized controlled trialsHailan Zou, Lili Liu, Jia Guo, et al.Journal of Diabetes Investigation|November 29, 2020
Admission hyperglycemia as an independent predictor of long-term prognosis in acute myocardial infarction patients without diabetes: A retrospective studyCai-Yan Cui, Ming-Gang Zhou, Lian-Chao Cheng, et al.Journal of Diabetes Investigation|December 15, 2018
Genetic variants in DNMT1 and the risk of cardiac autonomic neuropathy in women with type 1 diabetesDaniele Pereira Santos-Bezerra, Sharon Nina Admoni, Rosana Cristina Mori, et al.Journal of Diabetes Investigation|March 17, 2021
Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in JapanYukiko Onishi, Yoko Yoshida, Toshiko Takao, et al.Journal of Diabetes Investigation|November 20, 2021
miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolismChongge Pan, Menghuan Li, Jingzhou Wang, et al.Journal of Diabetes Investigation|November 30, 2021
Role of the adaptive immune system in diabetic kidney diseaseLingyun Kong, Sofianos Andrikopoulos, Richard J MacIsaac, et al.Journal of Diabetes Investigation|March 22, 2021
Dipeptidyl peptidase-4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetesTakahiro Abe, Yasuhiro Matsubayashi, Sayaka Muragishi, et al.Journal of Diabetes Investigation|March 24, 2021
Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patientsMin Kyung Kim, Doo-Man KimPageof 251